VKTX · Viking Therapeutics, Inc.

$34.79 -0.60 (-1.70%) At close · Jul 24

Market Cap

$4.04B

116.11M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

633,810 shares

as of 2015-05-31

Remaining Authorization

366,190 shares

as of 2015-05-31

Program Utilization

42.2% 267,620 shares used of 633,810 shares

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$6,795,000	—	—	10-K, filed 2025-02-26
2016-12-31	$229	—	—	10-K, filed 2018-03-07
2015-12-31	$38	—	—	10-K, filed 2017-03-21
2014-12-31	$2	—	—	10-K, filed 2016-03-08

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2022-12-31	$0 Δ	—	—	10-K, filed 2025-02-26
2022-09-30	$0 Δ	—	—	10-Q, filed 2023-10-25
2022-06-30	$1,674,000 Δ	—	—	10-Q, filed 2023-07-26
2022-03-31	$5,121,000	—	—	10-Q, filed 2023-04-26
2015-12-31	$0 Δ	—	—	10-K, filed 2017-03-21
2015-09-30	$0 Δ	—	—	10-Q, filed 2016-11-10
2014-03-31	$2	—	—	10-Q, filed 2015-06-12

Key facts CIK 1607678 CUSIP 92686J106 13F (30d) 73 filings 73 filers Visit website Investor relations